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Embryonic stem cells (ESCs) of mice and humans
have distinctmolecular and biological characteristics,
raising thequestionofwhetheranearlier, ‘‘naive’’ state
of pluripotency may exist in humans. Here we took a
systematic approach to identify small molecules that
support self-renewal of naive human ESCs based on
maintenance of endogenous OCT4 distal enhancer
activity, amolecular signature of ground state pluripo-
tency. Iterative chemical screening identified a combi-
nation of five kinase inhibitors that induces and main-
tains OCT4 distal enhancer activity when applied
directly to conventional humanESCs. These inhibitors
generate human pluripotent cells in which transcrip-
tion factors associatedwith the groundstate of plurip-
otency are highly upregulated and bivalent chromatin
domains are depleted. Comparison with previously
reported naive human ESCs indicates that our condi-
tions capture a distinct pluripotent state in humans
that closely resembles that ofmouseESCs. This study
presents a framework for defining the culture require-
ments of naive human pluripotent cells.
INTRODUCTION
Human pluripotent stem cells, including embryonic stem cells
(ESCs) and induced pluripotent stem cells (iPSCs), share molec-
ular and functional properties with epiblast stem cells (EpiSCs)
derived from the mouse postimplantation epiblast (Brons et al.,
2007; Tesar et al., 2007). It has been suggested that these cells
represent a primed state of pluripotency that is distinct from the
naive pluripotent ground state of mouse ESCs and iPSCs (Nich-
ols and Smith, 2009). EpiSCs can be converted to naive pluripo-
tency by combined chemical and genetic manipulation (Guo
et al., 2009; Hanna et al., 2009; Silva et al., 2009). A questionCeof significant interest is whether human ESCs can be converted
to the naive state. Initial studies reported that dual inhibition of
MEK and GSK3 (2i), leukemia inhibitory factor (LIF), and overex-
pression of transcription factors associated with naive pluripo-
tency can induce features of ground state pluripotency in human
ESCs (Hanna et al., 2010; Wang et al., 2011).
Recently, several groups have described culture conditions for
maintaining transgene-independent human ESCs that share
various properties with mouse ESCs (Chan et al., 2013; Gafni
et al., 2013; Valamehr et al., 2014; Ware et al., 2014). Of note,
Hanna and colleagues tested combinations of 16 inhibitors and
growth factors for maintenance of OCT4-GFP expression (Gafni
et al., 2013). Because Oct4 is equally expressed betweenmouse
ESCs and EpiSCs (Brons et al., 2007; Tesar et al., 2007), this
marker does not distinguish a priori between naive and primed
states. The most compelling evidence for acquisition of naive
pluripotency in this study was the reported contribution of naive
human ESCs to interspecies chimeras after their injection into
mouse morulae (Gafni et al., 2013). Ng and colleagues screened
a combination of 20 compounds for enhanced expression of
NANOG in mTesr1, a customized medium for human ESCs con-
taining high levels of FGF and TGFb. This study reported that a
combination of 2i, hLIF, and Dorsomorphin induced upregulation
of a number of genes expressed in the human preimplantation
embryo (Chan et al., 2013). In contrast with these two studies,
two other recent papers reported that 2i and FGF are sufficient
to maintain naive-like human ESCs in the presence (Valamehr
et al., 2014) or absence (Ware et al., 2014) of hLIF.
Here we established a specific reporter system for naive
human pluripotency using transcription activator-like effector
nuclease (TALEN)-based genome editing, and we performed
an iterative chemical screen to identify kinase inhibitors that
induce and maintain activity of this reporter. These optimized
conditions enable both the interconversion between conven-
tional and naive human ESCs in the absence of reprogramming
factors and the direct isolation of naive ESCs from human blas-
tocysts. We also evaluate previously reported protocols for
capturing naive human ESCs and observe substantial differ-
ences with our cells in terms of reporter activity, transcriptionalll Stem Cell 15, 471–487, October 2, 2014 ª2014 The Authors 471
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postulate that our combination of kinase inhibitors captures a
distinct state of human pluripotency that shares defining features
with mouse ESCs.
RESULTS
A Reporter System for Naive Human Pluripotency Based
on OCT4 Distal Enhancer Activity
An important molecular signature of naive pluripotency in the
mouse system is the use of the distal enhancer (DE) of OCT4.
This element controls Oct4 expression in naive mouse ESCs,
preimplantation mouse embryos, and germ cells (Yeom et al.,
1996). In contrast, expression of Oct4 in primed EpiSCs and in
the mouse postimplantation embryo is under the control of the
proximal enhancer (PE) element (Tesar et al., 2007). To detect
rare naive human ESCs in a large population of primed cells,
we engineered a reporter system for OCT4 DE activity using
TALENs. We deleted the PE element from an OCT4-2A-GFP
allele (Hockemeyer et al., 2011) (Figure 1A and Figure S1A avail-
able online). TALENs were designed to cleave in the 50 end of the
PE, together with a donor vector containing LoxP sites bordering
a selectable marker and gene sequences homologous to those
flanking the PE. After being targeted, the allele harbors an
approximately 1 kb deletion of the PE sequence. We confirmed
successful integration of this PE targeting vector (Figure 1B) and
subsequent removal of the selection cassette (Figure S1A). As
expected, deletion of the PE resulted in substantial attenuation
of the OCT4-2A-GFP signal in the resulting OCT4WT/DPE-GFP
(from here on referred to as OCT4-DPE-GFP) primed human
ESCs (Figure 1C). Single-molecule (sm) RNA FISH analysis in in-
dividual cells showed that GFP expression was diminished while
OCT4 expression was reduced approximately by 50% after PE
removal (Figure 1D). These changes in OCT4 and GFP expres-
sion indicate that OCT4 is predominantly transcribed from the
wild-type allele containing an intact PE sequence rather than
the OCT4-DPE-GFP allele. Hence, OCT4 expression in primed
human ESCs is primarily dependent on the PE rather than the
DE, as observed in mouse EpiSCs.Figure 1. A Reporter System for Naive Human Pluripotency Based on
(A) Proximal enhancer (PE) targeting strategy in human ESCs containing a 2A-GF
(B) Southern blot analysis confirming disruption of PE in OCT4-2A-GFP ESCs.
Expected fragment size: WT (wild-type) = 5.6 kb, T (targeted) = 6.4 kb.
(C) Images of OCT4-2A-GFP human ESCs before (left) and after (right) TALEN-m
(D) Single-molecule RNA FISH analysis for OCT4 and GFP transcripts in OCT4-2
(E) Flow cytometric analysis of the proportion of OCT4-DPE-GFP+ cells obtained
infection WIBR3 human ESCs containing theOCT4-DPE-GFP reporter allele were
DOX for 1 week. R1, total proportion of GFP+ cells, includes weak GFP activity
observed only upon combined overexpression of KLF2+NANOG.
(F) Phase and fluorescence images and flow cytometric analysis of a clonal line
rescence images and flow cytometric analysis after replating in the absence of D
(G) Quantitative gene expression analysis for lentiviral FUW-KLF2, lentiviral FUW-
in hESM and clonal OCT4-DPE-GFP+ derivatives generated in 2i/L/DOX. Error b
(H) Phase and fluorescence images of primitive neural stem cells (pNSCs) derive
three passages. 1003 magnification.
(I) Immunofluorescence staining for OCT4 and NESTIN in a clonal line of OCT4-DP
derived in 2i/L. 1003 magnification.
(J) Model representing the distinct phenotypic responses of hESCs to treatment
maintain reporter activity upon transgene withdrawal. OCT4-DPE-GFP+ cells can
and FGF.
CeWe investigated whether overexpression of transcription fac-
tors specific to naive pluripotency together with the application
of serum-free 2i and hLIF (2i/L) conditions would result in
augmented OCT4-DPE-GFP activity. We overexpressed the
transcription factors KLF2 and NANOG using doxycycline
(DOX)-inducible lentiviral expression vectors. Compared to its
family members Klf4 and Klf5, Klf2 has an enhanced capability
to induce naive pluripotency in mouse EpiSCs (Hall et al.,
2009). In addition, the homeodomain transcription factor Nanog
is critical for the establishment of naive pluripotency (Silva et al.,
2009) and can revert EpiSCs to the naive state in the absence of
kinase inhibition (Theunissen et al., 2011). Consistent with the
potent effects of these factors in the mouse system, we found
that combined overexpression of KLF2 and NANOG in primed
human ESCs resulted in increased OCT4-DPE-GFP reporter
levels in a fraction of cells (Figure 1E and Figure S1B). The
appearance of cells with increased levels of reporter activity
was dependent on the expression of both factors and could
only be observed in the presence of 2i/L/DOX. GFP+ colonies
were clonally expanded on a mouse embryonic fibroblast
(MEF) feeder layer in the presence of 2i/L/DOX while retaining
a dome-like colony morphology and pluripotency gene expres-
sion (Figures 1F and 1G). Strikingly, withdrawal of DOX-depen-
dent KLF2 and NANOG expression resulted in the rapid loss of
colony morphology, the appearance of differentiated cells, and
the shutdown of OCT4-DPE-GFP reporter activity within 7 days
(Figure 1F, right). Thus, 2i/L culture conditions are insufficient
to maintain the self-renewal of OCT4-DPE-GFP+ cells after
withdrawal of exogenous factor expression. We considered
that the rapid downregulation of naive reporter activity provides
a defined time window in which to screen for small molecules
that support the maintenance of a putative naive human pluripo-
tent state.
Our inability to maintain OCT4-DPE-GFP activity in 2i/L led us
to further investigate the consequences of these culture condi-
tions when applied directly to conventional human ESCs in the
absence of transgene expression. In the mouse system dual
MEK and GSK3 inhibition is thought to consolidate the ground
state and eliminate EpiSCs and other differentiated phenotypesEndogenous OCT4 Distal Enhancer Activity
P sequence in frame with the 30 UTR of OCT4.
NdeI-digested genomic DNA was hybridized with 50 and 30 external probes.
ediated deletion of the PE. 403 magnification.
A-GFP human ESCs before and after TALEN-mediated disruption of the PE.
after DOX induction of lentiviral KLF2, NANOG, or KLF2+NANOG. After primary
trypsinized and treated with primed human ESCmedium (hESM), 2i/L, or 2i/L/
observed in primed human ESCs; R2, subset of cells with high GFP activity
of WIBR3 OCT4-DPE-GFP+ cells derived in 2i/L/DOX (left). Phase and fluo-
OX for 1 week (right) are also shown. 403 magnification.
NANOG, endogenous OCT4, and endogenous KLF4 in WIBR3 hESCs cultured
ars indicate ± 1 SD of technical replicates.
d by treating WIBR3 hESCs containing the OCT4-DPE-GFP allele with 2i/L for
E-GFP+ cells derived in 2i/L/DOX and a clonal line of OCT4-DPE-GFP pNSCs
with 2i/L and 2i/L/DOX. OCT4-DPE-GFP+ cells generated in 2i/L/DOX do not
revert back to the conventional ‘‘primed’’ hESC state by re-exposure to serum
ll Stem Cell 15, 471–487, October 2, 2014 ª2014 The Authors 473
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Smith, 2008). In contrast, we observed rapid expansion in
serum-free 2i/L of initially dome-shaped human ESC colonies
that assumed a neural morphology upon further passaging (Fig-
ure 1H). Flow cytometric analysis revealed that weak levels of
OCT4-DPE-GFP detected in primed human ESCs completely
disappeared in 2i/L alone (Figure 1E). Consistent with the
morphological change, we observed the loss of OCT4 and
NANOG expression and upregulation of NESTIN and PAX6
expression in primed human ESCs expanded in serum-free 2i/
L medium (Figure 1I and Figures S1C and S1D). These observa-
tions are in agreement with a report that 2i/L treatment induces
differentiation of human ESCs into primitive neural stem cells
(Hirano et al., 2012). We conclude that 2i/L conditions do not
interfere with expansion of differentiated cell types in human
cells to the same extent as in the mouse system and are conse-
quently insufficient for stabilizing naive human pluripotency
(Figure 1J).
Identification of Compounds that Maintain Naive
Reporter Activity upon Transgene Withdrawal
To identify compounds that sustain OCT4-DPE-GFP activity in
the absence of KLF2 and NANOG expression, we screened a ki-
nase inhibitor library in the presence of 2i/L for a period of 7 days
after DOX withdrawal in 96-well format (Figure 2A). This screen
identified 10 different hit compounds that partially rescued the
proportion of GFP+ cells when assayed by high-throughput
FACS analysis (Figures 2B–2C and Figure S2A). Notable among
these hits were four separate inhibitors of BRAF and four inhibi-
tors of upstream receptor tyrosine kinases (RTKs) including
DDR1, VEGFR1/2, and FGFR1. We then performed a validation
experiment in 6-well format by withdrawing DOX and culturing
the cells in 2i/L supplemented with each hit compound for up
to 10 passages (Figure 2D). Nearly all hit compounds maintained
a proportion of GFP+ cells similar to that observed with DOX.
However, we noticed that the BRAF inhibitor SB590885 pre-
served the best colonymorphology and proliferation. In contrast,
treatment with the FGF receptor inhibitor PD173074 or pan-RTK
inhibitor WZ-4-145 resulted in maintenance of OCT4-DPE-
GFP activity in colonies with a disorganized morphology.
Gene expression analysis five passages after DOX withdrawal
confirmed the absence of KLF2 and NANOG transgene expres-
sion and the retention of endogenous OCT4 and GFP transcripts
(Figure 2E and Figure S2B). To validate these findings in an inde-Figure 2. Identification of Small Molecules that Maintain OCT4-DPE-G
(A) Strategy for screening a kinase inhibitor library to identify compounds that m
KLF2 and NANOG expression.
(B) Raw data obtained from high-throughput flow cytometric analysis of the prop
inhibitor library (n = 2).
(C) Hit compounds from maintenance screen using a clonal line of WIBR3 OCT4
(D) Phase images (top) and flow cytometric analysis of the proportion of OCT4-DP
DOX and maintained for 10 passages without DOX in the presence of each cand
(E) Quantitative gene expression analysis for lentiviral FUW-KLF2, lentiviral FUW-N
maintained in 2i/L/DOX or for five passages without DOX in the presence of eac
(F) Chemical structure of the BRAF inhibitor SB590885.
(G) Phase images of a clonal line of WIBR3 human ESCs established in 2i/L u
maintained for eight passages without DOX in 2i/L/SB590885 (1 mM) (bottom). 4
(H) Quantitative gene expression analysis for lentiviral FUW-KLF2, lentiviral FUW
maintained for eight passages without DOX in 2i/L/SB590885 (1 mM). Error bars
Cependent system, we introduced DOX-inducible KLF2 and
NANOG transgenes in a line of wild-type WIBR3 human ESCs.
Upon receiving application of DOX and 2i/L, dome-shaped
colonies appeared that could be expanded clonally. After DOX
withdrawal these lines were maintained in 2i/L/SB590885 while
retaining both colony morphology and the expression of endog-
enous OCT4 (Figures 2F–2H). Thus, high-throughput chemical
screening identified a number of kinase inhibitors, most notably
the BRAF inhibitor SB590885, that synergize with 2i/L to main-
tain OCT4-DPE-GFP reporter activity and pluripotency gene
expression in human ESCs after removal of exogenous KLF2
and NANOG expression.
Using a FACS-based live/dead discrimination assay, we
determined that cells maintained in 2i/L/SB590885 had reduced
viability (Figure S2C). This led us to consider whether other small
molecules could cooperate with 2i/L/SB590885 to improve the
fraction of viable GFP+ cells. Inclusion of a live/dead assay
enhanced the resolution of our 96-well high-throughput FACS
analysis, allowing more sensitive discrimination between the
proportion of viable OCT4-DPE-GFP+ cells cultured in 2i/L/
DOX and that of those cultured in 2i/L/SB590885 (Figure 3A).
We included this viability assay in a modified screen in which
GFP+ cells were cultured for two passages after DOXwithdrawal
in 2i/L/SB590885 supplemented with the kinase inhibitor library
(Figures 3B–3C and Figure S3A). This screen identified several
hit compounds that improved the fraction of viable GFP+ cells,
including the LCK/SRC inhibitor WH-4-023 (Figure S3B). We
also performed a titration of the concentrations of PD0325901,
CHIR99021, and SB590885 during two passages after DOX
withdrawal followed by high-throughput FACS analysis (Fig-
ure 3D). We observed a significant improvement in the pro-
portion of viable GFP+ cells using a concentration of 1 mM
PD0325901, 0.3 mM CHIR99021, and 0.5 mM SB590885.
Notably, lower concentrations of CHIR99021 improved the pro-
portion of viable GFP+ cells, whereas higher concentrations of
CHIR99021 had an opposite effect. This is reminiscent of recent
evidence that lowered GSK3 inhibition reduces differentiation
and enhances the self-renewal of rat ESCs (Meek et al., 2013).
The proportion of viable OCT4-DPE-GFP+ cells after DOX
withdrawal was further improved by a combination of optimized
concentrations of PD0325901, CHIR99021, and SB590885 with
1 mM WH-4-023 (Figure 3F). We also included the ROCK inhib-
itor Y-27632 (Figure S3C). Finally, we observed improved
morphology upon long-term culture without DOX by replacingFP Activity after Transgene Withdrawal
aintain OCT4-DPE-GFP reporter activity upon withdrawal of DOX-dependent
ortion of OCT4-DPE-GFP+ cells in 96-well plates supplemented with a kinase
-DPE-GFP+ ESCs established in 2i/L/DOX.
E-GFP+ cells (bottom) in a clonal line of OCT4-DPE-GFP+ cells derived in 2i/L/
idate compound. 403 magnification.
ANOG, endogenous OCT4, and GFP in a clonal line of OCT4-DPE-GFP+ cells
h candidate compound. Error bars indicate ± 1 SD of technical replicates.
pon DOX-mediated induction of KLF2 and NANOG (top), and the same line
03 magnification.
-NANOG, and endogenous OCT4 in two clonal lines of WIBR3 human ESCs
indicate ± 1 SD of technical replicates.
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Systematic Identification of Naive Human ESCsCHIR99021 with an alternative GSK3 inhibitor, IM12 (Figure 3G
and Figure S3D). Pluripotency of putative naive human ESCs
maintained under these conditions was confirmed by the gener-
ation of high-grade teratomas, including tissues representing all
three germ layers, after their subcutaneous injection into NOD/
SCID mice (Figure 3H). In summary, we have identified a combi-
nation of five compounds, including inhibitors of MEK, GSK3,
BRAF, ROCK, and SRC, which supports the expansion of viable
OCT4-DPE-GFP+ human pluripotent cells after exogenous tran-
scription factor expression has been removed.
Generation of Transgene-free Naive HumanESCs in 5i/L
We then investigated the consequences of applying our opti-
mized 5i/L medium to conventional human ESCs in the absence
of ectopic factor expression. Not surprisingly, this highly selec-
tive inhibitor cocktail generated widespread cell death within
2 days of treatment. However, we observed the emergence of
a small number of dome-shaped colonies within 10 days that
were positive for the OCT4-DPE-GFP reporter (Figure 4B). These
colonies were isolated and clonally expanded after dissociation
in trypsin (Figure 4B). The appearance of these OCT4-DPE-
GFP+ cells in our optimized chemical conditions suggested
that overexpression of KLF2 and NANOG may be dispensable
for driving primed human ESCs to the naive state. However,
the slow and inefficient kinetics of this chemical conversion event
led us to consider whether providing additional growth factor
support might boost the efficiency of naive cell induction. Provi-
sion of 5i/L supplemented with FGF and Activin A (5i/L/FA)
enhanced the kinetics of OCT4-DPE-GFP induction (Figure 4C)
and enabled conversion of wild-type WIBR2 primed human
ESCs into a cell state with identical morphology (Figure 4D) and
normal karyotype at passage 8 (Figure S4A). Given the selective
nature of the 5i culture regimen, we speculate that additional
growth factor support prolongs the time window during which
primed human ESCs are amenable to convert to the naive state.
We then consideredwhether these culture conditionswould sup-
port the direct derivation of ESC lines from human blastocysts.
Application of 5i/L/FA to human blastocyst outgrowths resulted
in the establishment of human ESCs with a similar dome-shaped
colony morphology (Figure 4E) and normal karyotype at passage
7 (Figure S4B). Furthermore, application of 5i/L/FA after activa-Figure 3. Optimization of Medium for Maintaining Viable OCT4-DPE-G
(A) Flow cytometric analyses of the proportion of OCT4-DPE-GFP+ cells in a 96-w
Top panel shows quantification of OCT4-DPE-GFP+ cells without including live/
cells after gating out DAPI+ cells.
(B) Strategy for screening a kinase inhibitor library to identify compounds that imp
DOX for two passages in 2i/L/SB590995 (1 mM).
(C) Raw data obtained from high-throughput flow cytometric analysis of the propo
plate of a kinase inhibitor library (n = 2). Hit compound WH-4-023 is indicated w
(D and E) High-throughput flow cytometric quantification of the proportion of D
passages (E) in 64 different concentrations of PD0325901, CHIR99021, and SB5
hibitors used in the preceding experiments (1 mM PD0325901, 3 mM CHIR99021
score at P2-DOX.
(F) Phase and fluorescence images (top) and flow cytometric analysis of the prop
cells derived in 2i/L/DOX and maintained for two passages without DOX in 2i/L/S
concentrations of PD0325901, CHIR99021 and SB590885 (see Figure 3E). 1003
(G) Phase and fluorescence images of a clonal line ofWIBR3OCT4-DPE-GFP+ ce
(right) and maintained for three passages in PD0325901/IM12/SB590885/Y-2763
(H) Teratoma generated from wild-type WIBR3 human ESCs maintained in PD
withdrawal. Representative tissues of the three germ layers are indicated. 2003
Cetion of OSK(M) in secondary C1 OCT4-DPE-GFP fibroblasts or
primary patient-derived fibroblasts enabled the isolation of naive
human iPSCs (Figure 4F and Figure S4C). Hence, 5i/L/FA pro-
motes induction of OCT4-DPE-GFP activity in the absence of
reprogramming transgenes and the derivation of putative naive
human pluripotent cells from blastocysts or fibroblasts.
Genome stability is a subject of considerable interest in human
pluripotent stem cell culture. It has been reported that single-cell
dissociation using trypsin can accelerate the acquisition of chro-
mosomal abnormalities (Chan et al., 2008).We have observed an
abnormal karyotype in several converted and embryo-derived
human ESC lines in 5i/L/FA. This suggests that naive human
ESCs may be susceptible to acquiring chromosomal abnormal-
ities, similar to previous observations with naive rat ESCs (Li
et al., 2008). Further work is needed to assess the long-term
karyotypic stability of naive human ESCs.
To investigate the role of individual components in 5i/L/FAme-
dium, we removed single kinase inhibitors or growth factors from
a clonal line of OCT4-DPE-GFP+ cells derived in the absence
of transgenes. Withdrawal of the MEK inhibitor PD0325901 or
BRAF inhibitor SB590885 resulted in the rapid and widespread
loss of colony morphology (Figure S4D), OCT4-DPE-GFP re-
porter activity (Figure 4G), and pluripotency gene expression
(Figure 4H and Figure S4E). Withdrawal of the SRC inhibitor
WH-4-023 caused a change in morphology (Figure S4D) and a
slight reduction in OCT4-DPE-GFP reporter activity (Figure 4G).
In addition, withdrawal of the ROCK inhibitor Y-27632 caused a
significant reduction in proliferation (Figure S4D). On the other
hand, withdrawal of recombinant FGF had no apparent effect
on any of the parameters examined, which is consistent with
this growth factor being involved in the maintenance of primed
pluripotency. Similarly, withdrawal of Activin A did not cause a
reduction in OCT4-DPE-GFP activity (Figure 4G). However, we
observed more differentiation and reduced expression of plurip-
otency genes when FGF and Activin A were removed together
(Figure 4H and Figures S4D and S4E). Surprisingly, reporter ac-
tivity and pluripotency gene expression were unaffected by the
removal of either GSK3 inhibition or hLIF (Figures 4G–4H and
Figure S4E). Therefore, the maintenance of OCT4-DPE-GFP re-
porter activity is dependent primarily on MEK inhibition and
BRAF inhibition, while robust proliferation of GFP+ cells requiresFP+ Cells
ell plate 1 week after culture in 2i/L/DOX, 2i/L alone, or 2i/L/SB590885 (1 mM).
dead discrimination. Bottom panel shows quantification of OCT4-DPE-GFP+
rove the fraction of viable (DAPI) OCT4-DPE-GFP+ cells maintained without
rtion of DAPI/OCT4-DPE-GFP+ cells in 96-well plates supplemented with one
ith chemical structure (Martin et al., 2006).
API/OCT4-DPE-GFP+ cells in 96 wells cultured for one passage (D) or two
90885. Asterisk denotes score of the standard concentration of the three in-
, and 1 mM SB590885). Arrows indicate concentrations producing the highest
ortion of OCT4-DPE-GFP+ cells (bottom) in a clonal line of OCT4-DPE-GFP+
B590885opt/Y-27632 or 2i/L/SB590885opt/Y-27632/WH-4-023. Opt, optimized
magnification.
lls (left) and a clonal line of wild-typeWIBR3 human ESCs generated in 2i/L/DOX
2/WH-4-023 (5i) and hLIF. 403 magnification.
0325901/IM12/SB590885/Y-27632/WH-4-023 (5i) and hLIF after transgene
magnification.
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Systematic Identification of Naive Human ESCsROCK inhibition. Recombinant FGF enhances the induction of
naive reporter activity but can be omitted in established GFP+
cells. Because the cells were grown on feeders we formally
cannot exclude the possibility that factors produced by the
MEFs contributed to cell growth.
Evaluation of Alternative Culture Systems for Naive
Human Pluripotency
Recently, several groups reported alternative conditions for
inducing a naive pluripotent state in conventional human ESCs
(Chan et al., 2013; Gafni et al., 2013; Valamehr et al., 2014;
Ware et al., 2014). Comparison of the culture components in
these studies with our media shows both commonalities and dif-
ferences (Figure 5A). All previously published protocols for naive
human pluripotency include 2i. Another ubiquitous component is
FGF, which is either added as a recombinant protein (Gafni et al.,
2013; Valamehr et al., 2014; Ware et al., 2014) or present at high
levels in mTesr basal medium (Chan et al., 2013). However, the
use of additional RTK or BRAF inhibitors, the primary hits from
our kinase inhibitor screen, was not previously reported. We
examined whether previously published culture conditions for
naive human pluripotency could activate our reporter system
for endogenous OCT4 distal enhancer activity. Remarkably,
increased levels of OCT4-DPE-GFP activity were exclusively
observed upon application of 5i/L/A (Figure 5B). Whereas the
naive conditions described in Gafni et al. (2013) were capable
of maintaining regular OCT4-GFP reporter activity after removal
of KLF2 and NANOG expression, these conditions did not main-
tain OCT4-DPE-GFP activity (Figure 5C). This result is consistent
with the observation that none of six JNK inhibitors and seven
p38 MAP kinase inhibitors present in the kinase inhibitor library
showed an ability to maintain OCT4-DPE-GFP activity after the
withdrawal of KLF2 and NANOG expression (Figure 2B and Fig-
ure S2A). These findings suggest that our combination of kinase
inhibitors induces a distinct state of human pluripotency.
We then considered whether the kinase inhibitors reported
by Hanna and colleagues may have an additive effect in combi-
nation with our 5i/L/A medium. Inclusion of the JNK inhibitor
SP600125 and/or p38 MAP kinase inhibitor BIRB796 did not
affect the proportion of OCT4-DPE-GFP+ cells (Figure S5A).
However, an increase in expression of KLF4 and KLF2 was
observed upon addition of SP600125 (Figure S5B). Another
difference between the naive human studies reported to dateFigure 4. Direct Conversion of Conventional Human ESCs to Naive Plu
(A) Strategy for assessing direct conversion of primed human ESCs into OCT4-D
(B) Phase and fluorescence images of emerging naive colony and expanded cell
and right panels are 403 magnification, and middle panel is 1003.
(C) Phase and fluorescence images and flow cytometric analyses of the proportio
and/or Activin A (FA). 403 magnification.
(D) Phase images of wild-type naive WIBR2 human ESCs converted in 5i/L supp
(E) Phase image of a primary human ESC line derived in 5i/L/FA from an explanted
ESC line 1 (WIN1). 1003 magnification.
(F) Top, green: strategy for generating secondary naive human iPSCs from secon
SOX2 and KLF4 transgenes and OCT4-DPE-GFP allele. Top, blue: cell culture m
Bottom: phase and fluorescence images of primary primed iPSCs and second
secondary iPSCs. 403 magnification.
(G) Flow cytometric analysis of the proportion of OCT4-DPE-GFP+ cells three pa
(H) Quantitative gene expression analysis for NANOG and KLF4 three passages a
cells. Error bars indicate ± 1 SD of technical replicates.
Ceis the use of 20% knockout serum replacement (KSR) or Albu-
max-containing medium (Gafni et al., 2013; Valamehr et al.,
2014; Ware et al., 2014) versus serum-free N2B27 medium
(this study). We therefore investigated the consequences of
applying our inhibitor cocktail in the presence of 20% KSR,
and we found that this switch in basal medium resulted in the
rapid attenuation of OCT4-DPE-GFP signal concomitant with
morphological changes (Figure 5D and Figure S5C). Hence, a
high concentration of KSR appears to be detrimental to naive
reporter activity independently of additional kinase inhibition. In
fact, a reduction in pluripotency gene expression was observed
upon provision of KSR or fetal bovine serum (FBS) at concentra-
tions >5% (Figure 5E). However, including 0.5%–1% KSR in
combination with 5i/L, JNK inhibition, and Activin A (6i/L/A)
enhanced the efficiency of OCT4-DPE-GFP induction from the
primed state (Figure 5F). We conclude that the induction and
maintenance of OCT4-DPE-GFP+ human ESCs is highly sensi-
tive to the choice of basal medium.
Molecular Characterization of Naive Human
Pluripotency
To characterize the gene expression profile of naive human
ESCs derived under our conditions, RNA was collected from
WIBR2 and WIBR3 human ESCs cultured in primed medium or
6i/L/A and embryo-derived Whitehead Institute Naive Human 1
(WIN1) ESCs cultured in 5i/L/A or 6i/L/A. We then performed
expression analysis on Affymetrix arrays using RNA spike-in
normalization (Love´n et al., 2012). Cross-species gene expres-
sion comparison demonstrated that primed WIBR2 and WIBR3
human ESCs clustered with primed mouse EpiSCs, while naive
human ESCs cultured in 5i/L/A or 6i/L/A clustered with naive
mouse ESCs (Figure 6A). Our naive human ESC samples clus-
tered together closely, and addition of the JNK inhibitor had little
impact on overall gene expression in the naive state (Figure 6A).
Themost upregulated gene ontology (GO) categories in the naive
state were associatedwith transcriptional control, while themost
downregulated categories were implicated in neural differentia-
tion and cell adhesion (Figure S6A). Intriguingly, our naive human
ESCs exhibited marked downregulation of the transcription
factors OTX2 and ZIC2/3, which were recently shown to direct
Oct4 to primed state-specific enhancer sites (Buecker et al.,
2014). A number of transcription factors typically associated
with the self-renewal and pluripotency of mouse ESCs rankedripotency in 5i/L
PE-GFP+ cells under optimized chemical conditions.
s from WIBR3 OCT4-DPE-GFP human ESCs treated with 5i/L for 10 days. Left
n of GFP+ cells during conversion experiments in 5i/L supplemented with FGF
lemented with FGF and/or Activin A (FA). 403 magnification.
human blastocyst. Cell line is designated asWhitehead Institute Naive Human
dary derived fibroblasts (Hockemeyer et al., 2008) harboring inducible OCT4,
edia conditions used at representative stages of reprogramming experiment.
ary derived fibroblasts and the reactivation of GFP in naive reprogrammed
ssages after withdrawal of individual inhibitors and growth factors.
fter withdrawal of individual inhibitors and growth factors from 5i/L/FA control
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including DPPA5, DPPA3 (also known as STELLA), DPPA2,
REX1, KLF4, KLF5, TFCP2L1, and NANOG (Figures 6B–6D and
Table S1 available online). Expression of these factors was
largely unaffected in the conditions for naive human pluripotency
described by Gafni et al. (2013) and Ware et al. (2014), whereas
several transcripts associated with naive pluripotency were up-
regulated, though not as significantly, in the conditions of Chan
et al. (2013) (Figure 6B). Upregulation of transcripts specific to
naive pluripotency under our conditions was confirmed by
qRT-PCR (Figure 6E and Figure S6B). However, we noticed
that expression of ESRRB was not significantly affected in 5i/
L/A compared to the primed state. This suggests that not all
aspects of the naive transcriptional program are conserved be-
tween mice and humans. A recent single-cell RNA-Seq analysis
revealed that markers of naive pluripotency were highly upregu-
lated at themorula and epiblast stages of human preimplantation
development compared to conventional (primed) human ESCs
(Yan et al., 2013) (Figure S6C). This suggests that our conditions
may reestablish an early preimplantation epiblast-specific gene
expression signature that is lost during derivation of human
ESCs under conventional conditions. Hence, 5i/L/A induces a
unique transcriptional profile in human ESCs, characterized by
upregulation of naive-specific transcription factors and suppres-
sion of neural differentiation genes.
It was surprising that, compared to XIST levels in primed hESM
conditions, XIST was upregulated in female WIBR2 and WIBR3
human ESCs cultured under our optimized conditions for naive
human pluripotency (Table S1). This raises the question of
whether the process was associated with X inactivation. Indeed,
consistent with XIST upregulation, analysis of X-linked gene
expression indicated that both female human ESC lines had un-
dergone X chromosome inactivation upon conversion in 6i/L/A
as shown in Figure 6F. Amoving averages expression plot shows
that the level of X-linked gene expression, while substantially
higher in the starting primed cells, was reduced to a level iden-
tical to that seen in male cells after conversion to the naive state.
These results raise the possibility that X inactivation in naive
pluripotent cells is different in the human as compared to the
mouse system.
A defining feature of ground state pluripotency in the mouse
system is that transcriptional regulators such as Nanog are ex-
pressed homogeneously (Wray et al., 2010). We therefore inves-
tigated whether human ESCs cultured under our conditions are
more homogeneous with respect to expression of NANOG by
sm RNA FISH analysis. The mean number of OCT4 mRNAs perFigure 5. Evaluation of Alternative Culture Conditions for Naive Huma
(A) Table comparing the components of four recent protocols for capturing naiv
version from Ware et al. (2014) involves preculture with the HDAC inhibitors buty
(B) Phase and fluorescence images and flow cytometric analyses showing the resp
human pluripotency (see Figure 5A) and 5i/L/A. 403 magnification.
(C) Quantification of the proportion of GFP+ cells in WIBR3 OCT4-GFP and OCT
expression in primed human ES medium (hESM) and four alternative conditions
(D) Flow cytometric analysis of the proportion of OCT4-DPE-GFP+ cells in 5i/L/A
versus 20% KSR basal medium.
(E) Quantitative gene expression analysis for OCT4, SOX2, KLF2, and NANOG in
FBS or KSR. Error bars indicate ± 1 SD of technical replicates.
(F) Phase and fluorescence images of induction of OCT4-DPE-GFP activity from th
KSR. 403 magnification.
Cecell was approximately similar between WIBR2 human ESCs
in primed medium, the naive medium of Gafni et al. (2013), and
5i/L/A (Figure 6G and Figure S7A). As expected from array and
qRT-PCR analyses (Figures 6C and 6E), the mean number
of NANOG mRNAs per cell was significantly higher in 5i/L/A
(Figure 6G and Figure S7A). Intriguingly, 5i/L/A culture also re-
sulted in reduced cell-to-cell variability in NANOG expression
compared to both primed medium and the naive medium of
Gafni et al. (2013) (Figure S7B). Thus, the increased expression
level of NANOG in 5i/L/A does not arise from a subset of cells,
but it is uniform across the population. We also confirmed by
RNA FISH that single cells cultured in 5i/L/A express significantly
higher numbers of KLF4 and REX1 mRNAs (Figure 6G). In
conclusion, our data suggest that expression profiling can serve
as an informative benchmark to distinguish different states of
primed and naive human pluripotency.
We performed chromatin immunoprecipitation followed
by DNA sequencing (ChIP-Seq) analysis to determine the
genome-wide distribution of the activation-associated marker
trimethylation of histone 3 lysine 4 (H3K4me3) and the tran-
scriptional-silencing-associated marker trimethylation of histone
3 lysine 27 (H3K27me3). Developmental genes with bivalent
domains marked by the presence of both H3K4me3 and
H3K27me3 in the primed state, such as HOXA9, FOXA2, and
GATA6, exhibited a reduced H3K27me3 signal in the naive state
(Figure 7A). We then examined the histone methylation profile
at loci encoding naive-specific pluripotency regulators. KLF2,
KLF4, and KLF5 were bivalent in the primed state, but they
almost entirely lost the H3K27me3 mark in the naive state (Fig-
ure 7B). Other markers of ground state pluripotency that are
highly upregulated in our system, such as DPPA5, DPPA3, and
REX1, acquired the H3K4me3 signal during conversion from
primed to naive pluripotency (Figure 7C). The core pluripotency
determinants OCT4, SOX2, and NANOG were marked exclu-
sively by H3K4me3 in naive and primed human ESCs (Figure 7D).
However, a slightly higher H3K4me3 signal was observed at the
NANOG promoter in the naive state, consistent with increased
transcription (Figure 6E). Finally, while H3K27me3 was generally
depleted from promoter regions in the naive state, some genes
that were strongly downregulated acquired H3K27me3 signal
(Figure 7E). Consistent with observations in naive pluripotent
mouse ESCs (Marks et al., 2012), H3K27me3 was strongly
reduced at the transcriptional start site (TSS) of Polycomb group
target genes in naive human ESCs (Figures 7F and 7G). We
conclude that the conversion from primed to naive human plu-
ripotency is accompanied by the dynamic rearrangement ofn Pluripotency
e-like human ESCs with 5i/L/A medium. Note that the protocol for naive con-
rate and suberoylanilide hydroxamic acid.
onse of OCT4-DPE-GFP primed cells to recently reported protocols for naive
4-DPE-GFP human ESCs upon removal of DOX-inducible KLF2 and NANOG
for naive human pluripotency.
and the JNK inhibitor SP600125 (6i/L/A) in serum-free N2B27 basal medium
human ESCs cultured in 6i/L/A and supplemented with 1%, 5%, 7.5%, or 10%
e primed state in 6i/L/A, and 6i/L/A supplemented with 1%, 5%, 7.5%, or 10%
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Figure 6. Transcriptional Profiling of Naive Human ESCs in 5i/L/A
(A) Cross-species hierarchical clustering of naive and primed pluripotent cells from mice and humans, as performed previously by Gafni et al. (2013). Affymetrix
expression data were normalized using RNA spike-in. Two groups of human ESC samples are included: WIBR2 (P12 and P14), WIBR3 (P9), and WIN1 (P10)
human ESCs derived in our optimized naive medium (5i/L/A or 6i/L/A, as indicated) and parental WIBR2 andWIBR3 human ESCs in primed human ESCmedium
(hESM). Correlation matrix of gene expression was clustered using Pearson correlation coefficients (PCCs). The average linkage hierarchical clustering of the
Pearson correlation is shown in the heatmap. mEpiSCs, mouse EpiSCs; mESC, mouse ESC; miPSC, mouse iPSC. Note that NOD miPSC samples described in
Hanna et al. (2009) were metastable and acquired an EpiSC-like identity after undergoing removal of exogenous transcription factors.
(B) Volcano plots showing fold change (x axis) between naive human ESC samples and primed human ESCs on all genes, as reported in this study, Gafni et al.
(2013), Chan et al. (2013), and Ware et al. (2014). The light blue dots represent those genes that exhibit the most significant gene expression changes (defined as
(legend continued on next page)
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Systematic Identification of Naive Human ESCsactivating and repressive histone modifications. In particular,
transcriptional upregulation of specific regulators of ground state
pluripotency is associated with the gain of H3K4me3 or loss of
H3K27me3 in a locus-specific manner.
Developmental Potential of Human ESCs in 5i/L/A
The classical assay for pluripotency of human ESCs and iPSCs is
to examine teratomas formed after their subcutaneous injection
into NOD/SCID mice. We found that naive human ESCs con-
verted under our optimized conditions contributed to high-grade
teratomas containing tissues representing all three germ layers,
regardless of the presence of FGF and Activin A in the medium
(Figure S7C). We also investigated the suitability of naive human
ESCs in directed differentiation. For this purpose we subjected
human ESCs derived from WIBR2 and WIBR3 primed cells in
5i/L/A to a five-step protocol for hepatic differentiation (Si-Tayeb
et al., 2010). We readily generated hepatocytes positive for the
mature markers AFP and HNF4a from both lines of naive ESCs
(Figure S7D).
In the mouse system, naive ESCs are functionally distin-
guished by their capability to colonize the embryo and contribute
to chimeric animals. In contrast, primed EpiSCs contribute
only very inefficiently to chimeras (Brons et al., 2007; Tesar
et al., 2007). Hanna and colleagues reported that human ESCs
cultured in the presence of 2i, hLIF, JNK inhibition, p38 inhibition,
FGF, and TGFb contributed robustly to interspecies chimeric
embryos after injection into mouse morulae (Gafni et al., 2013),
a result that provided a defining functional read-out for naive
human pluripotency. Therefore, we attempted to reproduce
this experiment using human ESCs containing constitutive GFP
or tdTomato transgenes in the AAVS1 locus. In total, we injected
860 embryos (eight-cell, morula, and blastocyst stages) with
GFP or tdTomato-labeled human ESCs cultured in 5i/L/A. We
also injected 436 embryos with C1-AAVS1-GFP cells provided
by the Hanna laboratory, which were cultured using the condi-
tions reported by Gafni et al. (2013). We recovered only a fraction
of embryos (43%–45%) from both experimental groups at E10.5,
suggesting that the majority of embryos had been reabsorbed.
No fluorescent signal was detected by microscopy in any em-
bryos recovered at E10.5 (Figure S7E). Thus, contribution of
human ESCs in 5i/L/A or the medium of Gafni et al. (2013) to
interspecies chimeras is in our hands too inefficient for detection
by standard visual inspection. Because interspecific chimera
formation is a complex and demanding assay, it is possible
that slight variations in cell culture conditions or embryo handling
could explain the different results.those that have a log2 fold change > 1 and < 1 and wherein p < 0.05). Highlighte
downregulated in the naive state, respectively.
(C) Fold changes in expression of naive pluripotency-associated transcripts in ou
human samples published by Gafni et al. (2013) versus primed human ESCs (red
(D) For comparison with (C), fold changes in expression of naive pluripotency-as
curated from a previously published study (Najm et al., 2011).
(E) Quantitative gene expression analysis for NANOG and STELLA in human ESCs
L/FA (P4). Error bars indicate ± 1 SD of technical replicates.
(F) Moving average plots of expressed genes along the X chromosome in female
three male control iPSCs in hESM (top) and converted naive human ESCs in 6i/
location of the centromere (Cen).
(G) Single-molecule (sm) RNA FISH analysis using OCT4, NANOG, KLF4, and RE
(2013), or 5i/L/A.
CeDISCUSSION
The morphological, molecular, and functional similarity between
human ESCs and mouse postimplantation epiblast-derived
EpiSCs has prompted widespread interest in capturing the
equivalent of a naive pluripotent stem cell in humans (De Los An-
geles et al., 2012; Nichols and Smith, 2009). At the outset of this
study, we considered that the identification of putative naive hu-
man ESCswould be greatly facilitated by the availability of a spe-
cific reporter system. In the mouse, enhancer-specific regulation
of Oct4 expression is a defining molecular distinction between
ESCs and EpiSCs in vitro (Brons et al., 2007; Tesar et al.,
2007) and between the inner cell mass (ICM) and postimplanta-
tion epiblast in vivo (Yeom et al., 1996). We therefore deleted
the primed-specific PE from an OCT4-2A-GFP allele using
TALEN-mediated genome editing in heterozygously targeted
OCT4WT/GFP human ESCs (Hockemeyer et al., 2011). The obser-
vation that GFP expression was downregulated after PE removal
demonstrated that this reporter behaves as expected in the
primed state. Conversely, OCT4-DPE-GFP activity was strongly
induced by combined overexpression of KLF2 and NANOG. We
then took a systematic approach to screen a diverse collection of
230 kinase inhibitors for their capacity to maintain OCT4-DPE-
GFP activity after the removal of ectopic KLF2 and NANOG
expression. Through iterative screening we identified a combi-
nation of five kinase inhibitors that maintained viable GFP+
cells upon transgene withdrawal. Moreover, this kinase inhibitor
cocktail was capable of inducing OCT4-DPE-GFP activity when
applied directly to conventional (primed) human ESCs in the
complete absence of reprogramming factors.
Previous studies describing the isolation of naive human ESCs
also reported transgene-free interconversion from primed to
naive pluripotency (Chan et al., 2013; Gafni et al., 2013; Valamehr
et al., 2014; Ware et al., 2014). However, these published proto-
cols did not induce endogenous OCT4-DPE-GFP activity in our
hands. This finding was surprising given that Gafni et al. (2013)
reported activation of luciferase and BAC reporter constructs
under the control of the DE of human OCT4, while Ware et al.
(2014) observed increased DNaseI hypersensitivity at the DE in
human ESCs derived in 2i and FGF. For a possible explanation
we speculate that activation of the DE of endogenous OCT4
may represent a more stringent criterion for the naive pluripotent
state than activation of a transgene. A case in point is the ready
activation of an Oct4 reporter transgene in the absence of
endogenousOct4 expression (Hou et al., 2013). We also noticed
a difference in the kinetics of primed to naive conversion usingd in red or green are genes of interest that are upregulated in the naive state or
r naive human ESC samples versus primed human ESCs (blue), and the naive
).
sociated transcripts in naive mouse ESCs versus primed mouse EpiSCs were
cultured in parallel in primedmedium, the medium of Gafni et al. (2013), and 5i/
primed human ESCs (WIBR2 and WIBR3 hESM) compared to the average of
L/A (bottom). Shown are representative genes on the X chromosome and the
X1 probes in human ESCs cultured in primed hESM, the medium of Gafni et al.
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Figure 7. Chromatin Landscape of Naive Human Pluripotency
(A–E) ChIP-Seq tracks for H3K4me3 and H3K27me3 in WIBR2 human ESCs cultured in primed hESM (red) or naive 6i/L/A medium (P18) (blue) at five classes of
genes: (A) developmental genes that are bivalent in the primed state and exhibit loss of H3K27me3 in the naive state; (B) naive pluripotency genes that are bivalent
in the primed state and exhibit loss of H3K27me3 in the naive state; (C) naive pluripotency genes that acquire H3K4me3 in the naive state; (D) master transcription
factors that have a signal for H3K4me3, but not H3K27me3, in both naive and primed states; and (E) genes that are strongly downregulated in the naive state and
acquire increased H3K27me3 signal.
(F) ChIP-Seq analysis for H3K4me3 and H3K27me3 at Polycomb target genes in WIBR2 human ESCs cultured in primed medium (left) or naive 6i/L/A
medium (right).
(G) Average H3K4me3 and H3K27me3 signal at Polycomb target genes in WIBR2 human ESCs cultured in primed medium (red) or naive 6i/L/A medium (blue).
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Systematic Identification of Naive Human ESCspreviously reported protocols: whereas the emergence of
naive colonies under our conditions is a relatively protracted
process (ca. 10 days) that occurs after widespread cell death,
the application of previously described naive conditions was
accompanied with little cell death and rapid expansion of the
cells. The slow conversion observed in 5i/L/A is consistent with
a reprogramming event toward a distinct cellular state, rather
than adaptation to an identity closer to conventional (primed) hu-
man ESCs. Critically, our conditions also induced a dramatic up-
regulation of transcription factors typically associated with naive
pluripotency and human preimplantation development. Thus,
our observations suggest that the chemical screens used in
this study have identified a distinct state of human pluripotency.
Our observation that conversion of primed human ESCs into a
naive state is associated with upregulation of XIST and inactiva-
tion of X-linked gene expression is unexpected because conver-
sion of mouse EpiSCs to the naive state leads to X chromosome
reactivation (Guo et al., 2009; Silva et al., 2009). Previous obser-
vations demonstrating that XIST is transcribed in the ICM of
humanblastocysts (Okamotoet al., 2011) suggested that thepro-
cessof X inactivation inhumanembryos isdifferent from that seen
in mouse and that the regulatory intersection between induction
of thenaivepluripotencycircuitry andXchromosome reactivation
maynot beconserved frommice to humans.However, our results
must be interpretedwith caution because they are based on con-
version of extensively passaged primedhumanESCs,whichmay
have undergone X chromosome erosion (Mekhoubad et al.,
2012). A more thorough examination of the state of X inactivation
will require thedirect derivation of naiveESCs from female human
blastocysts (the ESC lines derived in this study were all male).
This work suggests that the concept of naive human plu-
ripotency may need to be reevaluated. Previously described
protocols for capturing naive human ESCs may offer practical
advantages over conventional human ESCs, including enhanced
proliferation and single-cell cloning, which could benefit applica-
tions such as gene targeting. As such, these studies are of
considerable interest because they may facilitate the application
of human iPSCs in disease modeling and regenerative medicine.
However, here we describe a distinct state of human pluripo-
tency with a transcriptional and epigenomic profile that closely
resembles naive mouse pluripotency. This suggests that human
ESCs can exist in different pluripotent states with distinct biolog-
ical and functional characteristics.
Our work opens several avenues for future experimental work.
First, while the culture conditions described here generate
pluripotent cells that more closely approximate the naive state
of mouse ESCs, they fall short of establishing a ground state in
which self-renewal is fully independent of extrinsic instruction
(Ying et al., 2008). Thus, conditions will need to be developed
that support propagation of naive human ESCs in the absence
of feeders, recombinant growth factors, and cytokines. Second,
naive human ESCs derived in 5i/L/A proliferate slowly when
compared to mouse ESCs. Thus, it will be interesting to identify
culture conditions that lead to higher proliferation. In addition,
the long-term karyotypic stability of human ESCs in 5i/L/A needs
to be assessed. Finally, the examination of naive human pluripo-
tency is currently complicated by the absence of a defining func-
tional assay. The generation of interspecies chimeras by injec-
tion of human ESCs into mouse morulae was proposed as aCestringent assay for naive human pluripotency (Gafni et al.,
2013), but in our hands this assay proved too inefficient as a
routine functional assay. Further improvements in the culture
methods for naive human ESCs and techniques for whole-em-
bryo imaging may provide a better platform for assessing the
developmental potential of naive human ESCs in vivo. Alterna-
tively, the use of our optimized culture conditions to isolate
chimera-competent naive ESCs from nonhuman primates could
provide more rigorous evidence of naive pluripotency.
EXPERIMENTAL PROCEDURES
Cell Culture
Conventional (primed) human iPSC line C1 (Whitehead Institute Center for Hu-
man Stem Cell Research, Cambridge, MA) (Hockemeyer et al., 2008) and hu-
man ESC linesWIBR2 andWIBR3 (Whitehead Institute Center for Human Stem
Cell Research, Cambridge, MA) (Lengner et al., 2010) were maintained on
mitomycin C inactivated MEF feeder layers and passaged mechanically using
a drawn Pasteur pipette or enzymatically by treatment for 20 min with 1 mg/ml
Collagenase type IV (GIBCO) followed by sequential sedimentation steps
in human ESC medium (hESM) to remove single cells. Primed human ESCs
and human iPSCs were cultured in hESM—DMEM/F12 (Invitrogen) supple-
mented with 15% FBS (Hyclone), 5% KSR (Invitrogen), 1 mM glutamine
(Invitrogen), 1% nonessential amino acids (Invitrogen), penicillin-streptomycin
(Invitrogen), 0.1 mM b-mercaptoethanol (Sigma), and 4 ng/ml FGF2 (R&D sys-
tems). Naive human ESCs/hiPSCs were cultured on mitomycin C-inactivated
MEF feeder cells and were passaged every 5–7 days by a brief PBS wash fol-
lowed by single-cell dissociation using 3–5 min treatment with Accutase
(GIBCO) and centrifugation in fibroblast medium (DMEM [Invitrogen] supple-
mented with 10% FBS [Hyclone], 1 mM glutamine [Invitrogen], 1% nonessen-
tial amino acids [Invitrogen], penicillin-streptomycin [Invitrogen], and 0.1 mM
b-mercaptoethanol). For conversion of preexisting primed human ESC lines,
we seeded 2 3 105 trypsinized single cells on an MEF feeder layer in hESM
supplemented with ROCK inhibitor Y-27632 (Stemgent, 10 mM). One or two
days later, medium was switched to 5i/L/A-containing naive hESM. Following
an initial wave of widespread cell death, dome-shaped naive colonies ap-
peared within 10 days and could be picked or expanded polyclonally using
3–5 min treatment with Accutase (GIBCO) on an MEF feeder layer. Naive
human pluripotent cells were derived and maintained in serum-free N2B27-
based media supplemented with 5i/L/A. Medium (500 ml) was generated by
inclusion of the following: 240 ml DMEM/F12 (Invitrogen; 11320), 240 ml Neu-
robasal (Invitrogen; 21103), 5 ml N2 supplement (Invitrogen; 17502048), 10 ml
B27 supplement (Invitrogen; 17504044), 10 mg recombinant human LIF (made
in-house), 1 mM glutamine (Invitrogen), 1% nonessential amino acids (Invitro-
gen), 0.1 mM b-mercaptoethanol (Sigma), penicillin-streptomycin (Invitrogen),
50 mg/ml BSA (Sigma), and the following small molecules and cytokines:
PD0325901 (Stemgent, 1 mM), IM-12 (Enzo, 1 mM), SB590885 (R&D systems,
0.5 mM), WH-4-023 (A Chemtek, 1 mM), Y-27632 (Stemgent, 10 mM), and Acti-
vin A (Peprotech, 20 ng/ml). 0.5% KSR (GIBCO) can be included to enhance
conversion efficiency. FGF2 (R&D systems, 8 ng/ml) enhanced the generation
of OCT4-DPE-GFP+ cells from the primed state, but it was dispensable for
maintenance of naive human ESCs. Additional chemicals described in this
work include: CHIR99021 (Stemgent, 0.3–3 mM as indicated), SP600125
(R&D systems, 10 mM), PD173074 (Stemgent, 0.1 mM), SB431542 (Tocris,
5 mM), BIRB796 (Axon Medchem, 2 mM), and doxycycline (Sigma-Aldrich,
2 mg/ml). Tissue culturemedia were filtered using a low protein-binding binding
0.22 mM filter (Corning). Alternative formulations for naive human ESC culture
were followed as described elsewhere (Chan et al., 2013; Gafni et al., 2013;
Valamehr et al., 2014; Ware et al., 2014). All experiments in this paper were
performed under physiological oxygen conditions (5% O2, 3% CO2) in the
presence of a MEF feeder layer unless stated otherwise.
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